Global COVID-19 Vaccine Development Tools Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for COVID-19 Vaccine Development Tools, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Vaccine Development Tools.
The COVID-19 Vaccine Development Tools market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global COVID-19 Vaccine Development Tools market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the COVID-19 Vaccine Development Tools companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of COVID-19 Vaccine Development Tools companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The COVID-19 Vaccine Development Tools market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global COVID-19 Vaccine Development Tools market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the COVID-19 Vaccine Development Tools companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Thermo Fisher Scientific
- Pfizer Inc
- Celerion
- Cole-Parmer Instrument Company
- STEMCELL Technologies
- Illumina, Inc
- AB Sciex Private Limited
- Agilent Technologies
- Danaher Corporation
- Bio-Rad Laboratories
- Qiagen NV
- Merck KgaA
- Shimadzu Corporation
- PerkinElmer Inc
- Eurofins Scientific
- Aurora Biomed
- Sartorius AG
- Flow Cytometry
- Electron Microscopy
- Spectrometry
- Others
- Pharmaceutical Company
- Biotechnology Company
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of COVID-19 Vaccine Development Tools companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Vaccine Development Tools Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Flow Cytometry
1.2.3 Electron Microscopy
1.2.4 Spectrometry
1.2.5 Others
1.3 Market by Application
1.3.1 Global COVID-19 Vaccine Development Tools Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global COVID-19 Vaccine Development Tools Market Perspective (2018-2029)
2.2 COVID-19 Vaccine Development Tools Growth Trends by Region
2.2.1 Global COVID-19 Vaccine Development Tools Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 COVID-19 Vaccine Development Tools Historic Market Size by Region (2018-2023)
2.2.3 COVID-19 Vaccine Development Tools Forecasted Market Size by Region (2024-2029)
2.3 COVID-19 Vaccine Development Tools Market Dynamics
2.3.1 COVID-19 Vaccine Development Tools Industry Trends
2.3.2 COVID-19 Vaccine Development Tools Market Drivers
2.3.3 COVID-19 Vaccine Development Tools Market Challenges
2.3.4 COVID-19 Vaccine Development Tools Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top COVID-19 Vaccine Development Tools Players by Revenue
3.1.1 Global Top COVID-19 Vaccine Development Tools Players by Revenue (2018-2023)
3.1.2 Global COVID-19 Vaccine Development Tools Revenue Market Share by Players (2018-2023)
3.2 Global COVID-19 Vaccine Development Tools Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by COVID-19 Vaccine Development Tools Revenue
3.4 Global COVID-19 Vaccine Development Tools Market Concentration Ratio
3.4.1 Global COVID-19 Vaccine Development Tools Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Vaccine Development Tools Revenue in 2022
3.5 COVID-19 Vaccine Development Tools Key Players Head office and Area Served
3.6 Key Players COVID-19 Vaccine Development Tools Product Solution and Service
3.7 Date of Enter into COVID-19 Vaccine Development Tools Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 VACCINE DEVELOPMENT TOOLS BREAKDOWN DATA BY TYPE
4.1 Global COVID-19 Vaccine Development Tools Historic Market Size by Type (2018-2023)
4.2 Global COVID-19 Vaccine Development Tools Forecasted Market Size by Type (2024-2029)
5 COVID-19 VACCINE DEVELOPMENT TOOLS BREAKDOWN DATA BY APPLICATION
5.1 Global COVID-19 Vaccine Development Tools Historic Market Size by Application (2018-2023)
5.2 Global COVID-19 Vaccine Development Tools Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America COVID-19 Vaccine Development Tools Market Size (2018-2029)
6.2 North America COVID-19 Vaccine Development Tools Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America COVID-19 Vaccine Development Tools Market Size by Country (2018-2023)
6.4 North America COVID-19 Vaccine Development Tools Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe COVID-19 Vaccine Development Tools Market Size (2018-2029)
7.2 Europe COVID-19 Vaccine Development Tools Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe COVID-19 Vaccine Development Tools Market Size by Country (2018-2023)
7.4 Europe COVID-19 Vaccine Development Tools Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific COVID-19 Vaccine Development Tools Market Size (2018-2029)
8.2 Asia-Pacific COVID-19 Vaccine Development Tools Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Region (2018-2023)
8.4 Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America COVID-19 Vaccine Development Tools Market Size (2018-2029)
9.2 Latin America COVID-19 Vaccine Development Tools Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America COVID-19 Vaccine Development Tools Market Size by Country (2018-2023)
9.4 Latin America COVID-19 Vaccine Development Tools Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa COVID-19 Vaccine Development Tools Market Size (2018-2029)
10.2 Middle East & Africa COVID-19 Vaccine Development Tools Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country (2018-2023)
10.4 Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific COVID-19 Vaccine Development Tools Introduction
11.1.4 Thermo Fisher Scientific Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Pfizer Inc
11.2.1 Pfizer Inc Company Detail
11.2.2 Pfizer Inc Business Overview
11.2.3 Pfizer Inc COVID-19 Vaccine Development Tools Introduction
11.2.4 Pfizer Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.2.5 Pfizer Inc Recent Development
11.3 Celerion
11.3.1 Celerion Company Detail
11.3.2 Celerion Business Overview
11.3.3 Celerion COVID-19 Vaccine Development Tools Introduction
11.3.4 Celerion Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.3.5 Celerion Recent Development
11.4 Cole-Parmer Instrument Company
11.4.1 Cole-Parmer Instrument Company Company Detail
11.4.2 Cole-Parmer Instrument Company Business Overview
11.4.3 Cole-Parmer Instrument Company COVID-19 Vaccine Development Tools Introduction
11.4.4 Cole-Parmer Instrument Company Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.4.5 Cole-Parmer Instrument Company Recent Development
11.5 STEMCELL Technologies
11.5.1 STEMCELL Technologies Company Detail
11.5.2 STEMCELL Technologies Business Overview
11.5.3 STEMCELL Technologies COVID-19 Vaccine Development Tools Introduction
11.5.4 STEMCELL Technologies Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.5.5 STEMCELL Technologies Recent Development
11.6 Illumina, Inc
11.6.1 Illumina, Inc Company Detail
11.6.2 Illumina, Inc Business Overview
11.6.3 Illumina, Inc COVID-19 Vaccine Development Tools Introduction
11.6.4 Illumina, Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.6.5 Illumina, Inc Recent Development
11.7 AB Sciex Private Limited
11.7.1 AB Sciex Private Limited Company Detail
11.7.2 AB Sciex Private Limited Business Overview
11.7.3 AB Sciex Private Limited COVID-19 Vaccine Development Tools Introduction
11.7.4 AB Sciex Private Limited Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.7.5 AB Sciex Private Limited Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Detail
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies COVID-19 Vaccine Development Tools Introduction
11.8.4 Agilent Technologies Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.8.5 Agilent Technologies Recent Development
11.9 Danaher Corporation
11.9.1 Danaher Corporation Company Detail
11.9.2 Danaher Corporation Business Overview
11.9.3 Danaher Corporation COVID-19 Vaccine Development Tools Introduction
11.9.4 Danaher Corporation Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.9.5 Danaher Corporation Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Detail
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories COVID-19 Vaccine Development Tools Introduction
11.10.4 Bio-Rad Laboratories Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Qiagen NV
11.11.1 Qiagen NV Company Detail
11.11.2 Qiagen NV Business Overview
11.11.3 Qiagen NV COVID-19 Vaccine Development Tools Introduction
11.11.4 Qiagen NV Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.11.5 Qiagen NV Recent Development
11.12 Merck KgaA
11.12.1 Merck KgaA Company Detail
11.12.2 Merck KgaA Business Overview
11.12.3 Merck KgaA COVID-19 Vaccine Development Tools Introduction
11.12.4 Merck KgaA Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.12.5 Merck KgaA Recent Development
11.13 Shimadzu Corporation
11.13.1 Shimadzu Corporation Company Detail
11.13.2 Shimadzu Corporation Business Overview
11.13.3 Shimadzu Corporation COVID-19 Vaccine Development Tools Introduction
11.13.4 Shimadzu Corporation Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.13.5 Shimadzu Corporation Recent Development
11.14 PerkinElmer Inc
11.14.1 PerkinElmer Inc Company Detail
11.14.2 PerkinElmer Inc Business Overview
11.14.3 PerkinElmer Inc COVID-19 Vaccine Development Tools Introduction
11.14.4 PerkinElmer Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.14.5 PerkinElmer Inc Recent Development
11.15 Eurofins Scientific
11.15.1 Eurofins Scientific Company Detail
11.15.2 Eurofins Scientific Business Overview
11.15.3 Eurofins Scientific COVID-19 Vaccine Development Tools Introduction
11.15.4 Eurofins Scientific Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.15.5 Eurofins Scientific Recent Development
11.16 Aurora Biomed
11.16.1 Aurora Biomed Company Detail
11.16.2 Aurora Biomed Business Overview
11.16.3 Aurora Biomed COVID-19 Vaccine Development Tools Introduction
11.16.4 Aurora Biomed Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.16.5 Aurora Biomed Recent Development
11.17 Sartorius AG
11.17.1 Sartorius AG Company Detail
11.17.2 Sartorius AG Business Overview
11.17.3 Sartorius AG COVID-19 Vaccine Development Tools Introduction
11.17.4 Sartorius AG Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.17.5 Sartorius AG Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Vaccine Development Tools Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Flow Cytometry
1.2.3 Electron Microscopy
1.2.4 Spectrometry
1.2.5 Others
1.3 Market by Application
1.3.1 Global COVID-19 Vaccine Development Tools Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global COVID-19 Vaccine Development Tools Market Perspective (2018-2029)
2.2 COVID-19 Vaccine Development Tools Growth Trends by Region
2.2.1 Global COVID-19 Vaccine Development Tools Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 COVID-19 Vaccine Development Tools Historic Market Size by Region (2018-2023)
2.2.3 COVID-19 Vaccine Development Tools Forecasted Market Size by Region (2024-2029)
2.3 COVID-19 Vaccine Development Tools Market Dynamics
2.3.1 COVID-19 Vaccine Development Tools Industry Trends
2.3.2 COVID-19 Vaccine Development Tools Market Drivers
2.3.3 COVID-19 Vaccine Development Tools Market Challenges
2.3.4 COVID-19 Vaccine Development Tools Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top COVID-19 Vaccine Development Tools Players by Revenue
3.1.1 Global Top COVID-19 Vaccine Development Tools Players by Revenue (2018-2023)
3.1.2 Global COVID-19 Vaccine Development Tools Revenue Market Share by Players (2018-2023)
3.2 Global COVID-19 Vaccine Development Tools Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by COVID-19 Vaccine Development Tools Revenue
3.4 Global COVID-19 Vaccine Development Tools Market Concentration Ratio
3.4.1 Global COVID-19 Vaccine Development Tools Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Vaccine Development Tools Revenue in 2022
3.5 COVID-19 Vaccine Development Tools Key Players Head office and Area Served
3.6 Key Players COVID-19 Vaccine Development Tools Product Solution and Service
3.7 Date of Enter into COVID-19 Vaccine Development Tools Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 VACCINE DEVELOPMENT TOOLS BREAKDOWN DATA BY TYPE
4.1 Global COVID-19 Vaccine Development Tools Historic Market Size by Type (2018-2023)
4.2 Global COVID-19 Vaccine Development Tools Forecasted Market Size by Type (2024-2029)
5 COVID-19 VACCINE DEVELOPMENT TOOLS BREAKDOWN DATA BY APPLICATION
5.1 Global COVID-19 Vaccine Development Tools Historic Market Size by Application (2018-2023)
5.2 Global COVID-19 Vaccine Development Tools Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America COVID-19 Vaccine Development Tools Market Size (2018-2029)
6.2 North America COVID-19 Vaccine Development Tools Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America COVID-19 Vaccine Development Tools Market Size by Country (2018-2023)
6.4 North America COVID-19 Vaccine Development Tools Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe COVID-19 Vaccine Development Tools Market Size (2018-2029)
7.2 Europe COVID-19 Vaccine Development Tools Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe COVID-19 Vaccine Development Tools Market Size by Country (2018-2023)
7.4 Europe COVID-19 Vaccine Development Tools Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific COVID-19 Vaccine Development Tools Market Size (2018-2029)
8.2 Asia-Pacific COVID-19 Vaccine Development Tools Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Region (2018-2023)
8.4 Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America COVID-19 Vaccine Development Tools Market Size (2018-2029)
9.2 Latin America COVID-19 Vaccine Development Tools Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America COVID-19 Vaccine Development Tools Market Size by Country (2018-2023)
9.4 Latin America COVID-19 Vaccine Development Tools Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa COVID-19 Vaccine Development Tools Market Size (2018-2029)
10.2 Middle East & Africa COVID-19 Vaccine Development Tools Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country (2018-2023)
10.4 Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific COVID-19 Vaccine Development Tools Introduction
11.1.4 Thermo Fisher Scientific Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Pfizer Inc
11.2.1 Pfizer Inc Company Detail
11.2.2 Pfizer Inc Business Overview
11.2.3 Pfizer Inc COVID-19 Vaccine Development Tools Introduction
11.2.4 Pfizer Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.2.5 Pfizer Inc Recent Development
11.3 Celerion
11.3.1 Celerion Company Detail
11.3.2 Celerion Business Overview
11.3.3 Celerion COVID-19 Vaccine Development Tools Introduction
11.3.4 Celerion Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.3.5 Celerion Recent Development
11.4 Cole-Parmer Instrument Company
11.4.1 Cole-Parmer Instrument Company Company Detail
11.4.2 Cole-Parmer Instrument Company Business Overview
11.4.3 Cole-Parmer Instrument Company COVID-19 Vaccine Development Tools Introduction
11.4.4 Cole-Parmer Instrument Company Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.4.5 Cole-Parmer Instrument Company Recent Development
11.5 STEMCELL Technologies
11.5.1 STEMCELL Technologies Company Detail
11.5.2 STEMCELL Technologies Business Overview
11.5.3 STEMCELL Technologies COVID-19 Vaccine Development Tools Introduction
11.5.4 STEMCELL Technologies Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.5.5 STEMCELL Technologies Recent Development
11.6 Illumina, Inc
11.6.1 Illumina, Inc Company Detail
11.6.2 Illumina, Inc Business Overview
11.6.3 Illumina, Inc COVID-19 Vaccine Development Tools Introduction
11.6.4 Illumina, Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.6.5 Illumina, Inc Recent Development
11.7 AB Sciex Private Limited
11.7.1 AB Sciex Private Limited Company Detail
11.7.2 AB Sciex Private Limited Business Overview
11.7.3 AB Sciex Private Limited COVID-19 Vaccine Development Tools Introduction
11.7.4 AB Sciex Private Limited Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.7.5 AB Sciex Private Limited Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Detail
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies COVID-19 Vaccine Development Tools Introduction
11.8.4 Agilent Technologies Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.8.5 Agilent Technologies Recent Development
11.9 Danaher Corporation
11.9.1 Danaher Corporation Company Detail
11.9.2 Danaher Corporation Business Overview
11.9.3 Danaher Corporation COVID-19 Vaccine Development Tools Introduction
11.9.4 Danaher Corporation Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.9.5 Danaher Corporation Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Detail
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories COVID-19 Vaccine Development Tools Introduction
11.10.4 Bio-Rad Laboratories Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Qiagen NV
11.11.1 Qiagen NV Company Detail
11.11.2 Qiagen NV Business Overview
11.11.3 Qiagen NV COVID-19 Vaccine Development Tools Introduction
11.11.4 Qiagen NV Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.11.5 Qiagen NV Recent Development
11.12 Merck KgaA
11.12.1 Merck KgaA Company Detail
11.12.2 Merck KgaA Business Overview
11.12.3 Merck KgaA COVID-19 Vaccine Development Tools Introduction
11.12.4 Merck KgaA Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.12.5 Merck KgaA Recent Development
11.13 Shimadzu Corporation
11.13.1 Shimadzu Corporation Company Detail
11.13.2 Shimadzu Corporation Business Overview
11.13.3 Shimadzu Corporation COVID-19 Vaccine Development Tools Introduction
11.13.4 Shimadzu Corporation Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.13.5 Shimadzu Corporation Recent Development
11.14 PerkinElmer Inc
11.14.1 PerkinElmer Inc Company Detail
11.14.2 PerkinElmer Inc Business Overview
11.14.3 PerkinElmer Inc COVID-19 Vaccine Development Tools Introduction
11.14.4 PerkinElmer Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.14.5 PerkinElmer Inc Recent Development
11.15 Eurofins Scientific
11.15.1 Eurofins Scientific Company Detail
11.15.2 Eurofins Scientific Business Overview
11.15.3 Eurofins Scientific COVID-19 Vaccine Development Tools Introduction
11.15.4 Eurofins Scientific Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.15.5 Eurofins Scientific Recent Development
11.16 Aurora Biomed
11.16.1 Aurora Biomed Company Detail
11.16.2 Aurora Biomed Business Overview
11.16.3 Aurora Biomed COVID-19 Vaccine Development Tools Introduction
11.16.4 Aurora Biomed Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.16.5 Aurora Biomed Recent Development
11.17 Sartorius AG
11.17.1 Sartorius AG Company Detail
11.17.2 Sartorius AG Business Overview
11.17.3 Sartorius AG COVID-19 Vaccine Development Tools Introduction
11.17.4 Sartorius AG Revenue in COVID-19 Vaccine Development Tools Business (2018-2023)
11.17.5 Sartorius AG Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global COVID-19 Vaccine Development Tools Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Flow Cytometry
Table 3. Key Players of Electron Microscopy
Table 4. Key Players of Spectrometry
Table 5. Key Players of Others
Table 6. Global COVID-19 Vaccine Development Tools Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global COVID-19 Vaccine Development Tools Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global COVID-19 Vaccine Development Tools Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global COVID-19 Vaccine Development Tools Market Share by Region (2018-2023)
Table 10. Global COVID-19 Vaccine Development Tools Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global COVID-19 Vaccine Development Tools Market Share by Region (2024-2029)
Table 12. COVID-19 Vaccine Development Tools Market Trends
Table 13. COVID-19 Vaccine Development Tools Market Drivers
Table 14. COVID-19 Vaccine Development Tools Market Challenges
Table 15. COVID-19 Vaccine Development Tools Market Restraints
Table 16. Global COVID-19 Vaccine Development Tools Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global COVID-19 Vaccine Development Tools Market Share by Players (2018-2023)
Table 18. Global Top COVID-19 Vaccine Development Tools Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Vaccine Development Tools as of 2022)
Table 19. Ranking of Global Top COVID-19 Vaccine Development Tools Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by COVID-19 Vaccine Development Tools Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players COVID-19 Vaccine Development Tools Product Solution and Service
Table 23. Date of Enter into COVID-19 Vaccine Development Tools Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global COVID-19 Vaccine Development Tools Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global COVID-19 Vaccine Development Tools Revenue Market Share by Type (2018-2023)
Table 27. Global COVID-19 Vaccine Development Tools Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global COVID-19 Vaccine Development Tools Revenue Market Share by Type (2024-2029)
Table 29. Global COVID-19 Vaccine Development Tools Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global COVID-19 Vaccine Development Tools Revenue Market Share by Application (2018-2023)
Table 31. Global COVID-19 Vaccine Development Tools Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global COVID-19 Vaccine Development Tools Revenue Market Share by Application (2024-2029)
Table 33. North America COVID-19 Vaccine Development Tools Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America COVID-19 Vaccine Development Tools Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America COVID-19 Vaccine Development Tools Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe COVID-19 Vaccine Development Tools Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe COVID-19 Vaccine Development Tools Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe COVID-19 Vaccine Development Tools Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific COVID-19 Vaccine Development Tools Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America COVID-19 Vaccine Development Tools Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America COVID-19 Vaccine Development Tools Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America COVID-19 Vaccine Development Tools Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa COVID-19 Vaccine Development Tools Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country (2024-2029) & (US$ Million)
Table 48. Thermo Fisher Scientific Company Detail
Table 49. Thermo Fisher Scientific Business Overview
Table 50. Thermo Fisher Scientific COVID-19 Vaccine Development Tools Product
Table 51. Thermo Fisher Scientific Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 52. Thermo Fisher Scientific Recent Development
Table 53. Pfizer Inc Company Detail
Table 54. Pfizer Inc Business Overview
Table 55. Pfizer Inc COVID-19 Vaccine Development Tools Product
Table 56. Pfizer Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 57. Pfizer Inc Recent Development
Table 58. Celerion Company Detail
Table 59. Celerion Business Overview
Table 60. Celerion COVID-19 Vaccine Development Tools Product
Table 61. Celerion Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 62. Celerion Recent Development
Table 63. Cole-Parmer Instrument Company Company Detail
Table 64. Cole-Parmer Instrument Company Business Overview
Table 65. Cole-Parmer Instrument Company COVID-19 Vaccine Development Tools Product
Table 66. Cole-Parmer Instrument Company Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 67. Cole-Parmer Instrument Company Recent Development
Table 68. STEMCELL Technologies Company Detail
Table 69. STEMCELL Technologies Business Overview
Table 70. STEMCELL Technologies COVID-19 Vaccine Development Tools Product
Table 71. STEMCELL Technologies Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 72. STEMCELL Technologies Recent Development
Table 73. Illumina, Inc Company Detail
Table 74. Illumina, Inc Business Overview
Table 75. Illumina, Inc COVID-19 Vaccine Development Tools Product
Table 76. Illumina, Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 77. Illumina, Inc Recent Development
Table 78. AB Sciex Private Limited Company Detail
Table 79. AB Sciex Private Limited Business Overview
Table 80. AB Sciex Private Limited COVID-19 Vaccine Development Tools Product
Table 81. AB Sciex Private Limited Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 82. AB Sciex Private Limited Recent Development
Table 83. Agilent Technologies Company Detail
Table 84. Agilent Technologies Business Overview
Table 85. Agilent Technologies COVID-19 Vaccine Development Tools Product
Table 86. Agilent Technologies Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 87. Agilent Technologies Recent Development
Table 88. Danaher Corporation Company Detail
Table 89. Danaher Corporation Business Overview
Table 90. Danaher Corporation COVID-19 Vaccine Development Tools Product
Table 91. Danaher Corporation Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 92. Danaher Corporation Recent Development
Table 93. Bio-Rad Laboratories Company Detail
Table 94. Bio-Rad Laboratories Business Overview
Table 95. Bio-Rad Laboratories COVID-19 Vaccine Development Tools Product
Table 96. Bio-Rad Laboratories Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 97. Bio-Rad Laboratories Recent Development
Table 98. Qiagen NV Company Detail
Table 99. Qiagen NV Business Overview
Table 100. Qiagen NV COVID-19 Vaccine Development Tools Product
Table 101. Qiagen NV Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 102. Qiagen NV Recent Development
Table 103. Merck KgaA Company Detail
Table 104. Merck KgaA Business Overview
Table 105. Merck KgaA COVID-19 Vaccine Development Tools Product
Table 106. Merck KgaA Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 107. Merck KgaA Recent Development
Table 108. Shimadzu Corporation Company Detail
Table 109. Shimadzu Corporation Business Overview
Table 110. Shimadzu Corporation COVID-19 Vaccine Development Tools Product
Table 111. Shimadzu Corporation Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 112. Shimadzu Corporation Recent Development
Table 113. PerkinElmer Inc Company Detail
Table 114. PerkinElmer Inc Business Overview
Table 115. PerkinElmer Inc COVID-19 Vaccine Development Tools Product
Table 116. PerkinElmer Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 117. PerkinElmer Inc Recent Development
Table 118. Eurofins Scientific Company Detail
Table 119. Eurofins Scientific Business Overview
Table 120. Eurofins Scientific COVID-19 Vaccine Development Tools Product
Table 121. Eurofins Scientific Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 122. Eurofins Scientific Recent Development
Table 123. Aurora Biomed Company Detail
Table 124. Aurora Biomed Business Overview
Table 125. Aurora Biomed COVID-19 Vaccine Development Tools Product
Table 126. Aurora Biomed Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 127. Aurora Biomed Recent Development
Table 128. Sartorius AG Company Detail
Table 129. Sartorius AG Business Overview
Table 130. Sartorius AG COVID-19 Vaccine Development Tools Product
Table 131. Sartorius AG Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 132. Sartorius AG Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 1. Global COVID-19 Vaccine Development Tools Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Flow Cytometry
Table 3. Key Players of Electron Microscopy
Table 4. Key Players of Spectrometry
Table 5. Key Players of Others
Table 6. Global COVID-19 Vaccine Development Tools Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global COVID-19 Vaccine Development Tools Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global COVID-19 Vaccine Development Tools Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global COVID-19 Vaccine Development Tools Market Share by Region (2018-2023)
Table 10. Global COVID-19 Vaccine Development Tools Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global COVID-19 Vaccine Development Tools Market Share by Region (2024-2029)
Table 12. COVID-19 Vaccine Development Tools Market Trends
Table 13. COVID-19 Vaccine Development Tools Market Drivers
Table 14. COVID-19 Vaccine Development Tools Market Challenges
Table 15. COVID-19 Vaccine Development Tools Market Restraints
Table 16. Global COVID-19 Vaccine Development Tools Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global COVID-19 Vaccine Development Tools Market Share by Players (2018-2023)
Table 18. Global Top COVID-19 Vaccine Development Tools Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Vaccine Development Tools as of 2022)
Table 19. Ranking of Global Top COVID-19 Vaccine Development Tools Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by COVID-19 Vaccine Development Tools Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players COVID-19 Vaccine Development Tools Product Solution and Service
Table 23. Date of Enter into COVID-19 Vaccine Development Tools Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global COVID-19 Vaccine Development Tools Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global COVID-19 Vaccine Development Tools Revenue Market Share by Type (2018-2023)
Table 27. Global COVID-19 Vaccine Development Tools Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global COVID-19 Vaccine Development Tools Revenue Market Share by Type (2024-2029)
Table 29. Global COVID-19 Vaccine Development Tools Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global COVID-19 Vaccine Development Tools Revenue Market Share by Application (2018-2023)
Table 31. Global COVID-19 Vaccine Development Tools Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global COVID-19 Vaccine Development Tools Revenue Market Share by Application (2024-2029)
Table 33. North America COVID-19 Vaccine Development Tools Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America COVID-19 Vaccine Development Tools Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America COVID-19 Vaccine Development Tools Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe COVID-19 Vaccine Development Tools Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe COVID-19 Vaccine Development Tools Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe COVID-19 Vaccine Development Tools Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific COVID-19 Vaccine Development Tools Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific COVID-19 Vaccine Development Tools Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America COVID-19 Vaccine Development Tools Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America COVID-19 Vaccine Development Tools Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America COVID-19 Vaccine Development Tools Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa COVID-19 Vaccine Development Tools Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa COVID-19 Vaccine Development Tools Market Size by Country (2024-2029) & (US$ Million)
Table 48. Thermo Fisher Scientific Company Detail
Table 49. Thermo Fisher Scientific Business Overview
Table 50. Thermo Fisher Scientific COVID-19 Vaccine Development Tools Product
Table 51. Thermo Fisher Scientific Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 52. Thermo Fisher Scientific Recent Development
Table 53. Pfizer Inc Company Detail
Table 54. Pfizer Inc Business Overview
Table 55. Pfizer Inc COVID-19 Vaccine Development Tools Product
Table 56. Pfizer Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 57. Pfizer Inc Recent Development
Table 58. Celerion Company Detail
Table 59. Celerion Business Overview
Table 60. Celerion COVID-19 Vaccine Development Tools Product
Table 61. Celerion Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 62. Celerion Recent Development
Table 63. Cole-Parmer Instrument Company Company Detail
Table 64. Cole-Parmer Instrument Company Business Overview
Table 65. Cole-Parmer Instrument Company COVID-19 Vaccine Development Tools Product
Table 66. Cole-Parmer Instrument Company Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 67. Cole-Parmer Instrument Company Recent Development
Table 68. STEMCELL Technologies Company Detail
Table 69. STEMCELL Technologies Business Overview
Table 70. STEMCELL Technologies COVID-19 Vaccine Development Tools Product
Table 71. STEMCELL Technologies Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 72. STEMCELL Technologies Recent Development
Table 73. Illumina, Inc Company Detail
Table 74. Illumina, Inc Business Overview
Table 75. Illumina, Inc COVID-19 Vaccine Development Tools Product
Table 76. Illumina, Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 77. Illumina, Inc Recent Development
Table 78. AB Sciex Private Limited Company Detail
Table 79. AB Sciex Private Limited Business Overview
Table 80. AB Sciex Private Limited COVID-19 Vaccine Development Tools Product
Table 81. AB Sciex Private Limited Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 82. AB Sciex Private Limited Recent Development
Table 83. Agilent Technologies Company Detail
Table 84. Agilent Technologies Business Overview
Table 85. Agilent Technologies COVID-19 Vaccine Development Tools Product
Table 86. Agilent Technologies Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 87. Agilent Technologies Recent Development
Table 88. Danaher Corporation Company Detail
Table 89. Danaher Corporation Business Overview
Table 90. Danaher Corporation COVID-19 Vaccine Development Tools Product
Table 91. Danaher Corporation Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 92. Danaher Corporation Recent Development
Table 93. Bio-Rad Laboratories Company Detail
Table 94. Bio-Rad Laboratories Business Overview
Table 95. Bio-Rad Laboratories COVID-19 Vaccine Development Tools Product
Table 96. Bio-Rad Laboratories Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 97. Bio-Rad Laboratories Recent Development
Table 98. Qiagen NV Company Detail
Table 99. Qiagen NV Business Overview
Table 100. Qiagen NV COVID-19 Vaccine Development Tools Product
Table 101. Qiagen NV Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 102. Qiagen NV Recent Development
Table 103. Merck KgaA Company Detail
Table 104. Merck KgaA Business Overview
Table 105. Merck KgaA COVID-19 Vaccine Development Tools Product
Table 106. Merck KgaA Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 107. Merck KgaA Recent Development
Table 108. Shimadzu Corporation Company Detail
Table 109. Shimadzu Corporation Business Overview
Table 110. Shimadzu Corporation COVID-19 Vaccine Development Tools Product
Table 111. Shimadzu Corporation Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 112. Shimadzu Corporation Recent Development
Table 113. PerkinElmer Inc Company Detail
Table 114. PerkinElmer Inc Business Overview
Table 115. PerkinElmer Inc COVID-19 Vaccine Development Tools Product
Table 116. PerkinElmer Inc Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 117. PerkinElmer Inc Recent Development
Table 118. Eurofins Scientific Company Detail
Table 119. Eurofins Scientific Business Overview
Table 120. Eurofins Scientific COVID-19 Vaccine Development Tools Product
Table 121. Eurofins Scientific Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 122. Eurofins Scientific Recent Development
Table 123. Aurora Biomed Company Detail
Table 124. Aurora Biomed Business Overview
Table 125. Aurora Biomed COVID-19 Vaccine Development Tools Product
Table 126. Aurora Biomed Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 127. Aurora Biomed Recent Development
Table 128. Sartorius AG Company Detail
Table 129. Sartorius AG Business Overview
Table 130. Sartorius AG COVID-19 Vaccine Development Tools Product
Table 131. Sartorius AG Revenue in COVID-19 Vaccine Development Tools Business (2018-2023) & (US$ Million)
Table 132. Sartorius AG Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global COVID-19 Vaccine Development Tools Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global COVID-19 Vaccine Development Tools Market Share by Type: 2022 VS 2029
Figure 3. Flow Cytometry Features
Figure 4. Electron Microscopy Features
Figure 5. Spectrometry Features
Figure 6. Others Features
Figure 7. Global COVID-19 Vaccine Development Tools Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global COVID-19 Vaccine Development Tools Market Share by Application: 2022 VS 2029
Figure 9. Pharmaceutical Company Case Studies
Figure 10. Biotechnology Company Case Studies
Figure 11. COVID-19 Vaccine Development Tools Report Years Considered
Figure 12. Global COVID-19 Vaccine Development Tools Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global COVID-19 Vaccine Development Tools Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global COVID-19 Vaccine Development Tools Market Share by Region: 2022 VS 2029
Figure 15. Global COVID-19 Vaccine Development Tools Market Share by Players in 2022
Figure 16. Global Top COVID-19 Vaccine Development Tools Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Vaccine Development Tools as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by COVID-19 Vaccine Development Tools Revenue in 2022
Figure 18. North America COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America COVID-19 Vaccine Development Tools Market Share by Country (2018-2029)
Figure 20. United States COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe COVID-19 Vaccine Development Tools Market Share by Country (2018-2029)
Figure 24. Germany COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific COVID-19 Vaccine Development Tools Market Share by Region (2018-2029)
Figure 32. China COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America COVID-19 Vaccine Development Tools Market Share by Country (2018-2029)
Figure 40. Mexico COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa COVID-19 Vaccine Development Tools Market Share by Country (2018-2029)
Figure 44. Turkey COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Thermo Fisher Scientific Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 47. Pfizer Inc Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 48. Celerion Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 49. Cole-Parmer Instrument Company Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 50. STEMCELL Technologies Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 51. Illumina, Inc Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 52. AB Sciex Private Limited Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 53. Agilent Technologies Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 54. Danaher Corporation Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 55. Bio-Rad Laboratories Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 56. Qiagen NV Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 57. Merck KgaA Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 58. Shimadzu Corporation Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 59. PerkinElmer Inc Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 60. Eurofins Scientific Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 61. Aurora Biomed Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 62. Sartorius AG Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Figure 1. Global COVID-19 Vaccine Development Tools Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global COVID-19 Vaccine Development Tools Market Share by Type: 2022 VS 2029
Figure 3. Flow Cytometry Features
Figure 4. Electron Microscopy Features
Figure 5. Spectrometry Features
Figure 6. Others Features
Figure 7. Global COVID-19 Vaccine Development Tools Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global COVID-19 Vaccine Development Tools Market Share by Application: 2022 VS 2029
Figure 9. Pharmaceutical Company Case Studies
Figure 10. Biotechnology Company Case Studies
Figure 11. COVID-19 Vaccine Development Tools Report Years Considered
Figure 12. Global COVID-19 Vaccine Development Tools Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global COVID-19 Vaccine Development Tools Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global COVID-19 Vaccine Development Tools Market Share by Region: 2022 VS 2029
Figure 15. Global COVID-19 Vaccine Development Tools Market Share by Players in 2022
Figure 16. Global Top COVID-19 Vaccine Development Tools Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Vaccine Development Tools as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by COVID-19 Vaccine Development Tools Revenue in 2022
Figure 18. North America COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America COVID-19 Vaccine Development Tools Market Share by Country (2018-2029)
Figure 20. United States COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe COVID-19 Vaccine Development Tools Market Share by Country (2018-2029)
Figure 24. Germany COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific COVID-19 Vaccine Development Tools Market Share by Region (2018-2029)
Figure 32. China COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America COVID-19 Vaccine Development Tools Market Share by Country (2018-2029)
Figure 40. Mexico COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa COVID-19 Vaccine Development Tools Market Share by Country (2018-2029)
Figure 44. Turkey COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia COVID-19 Vaccine Development Tools Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Thermo Fisher Scientific Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 47. Pfizer Inc Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 48. Celerion Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 49. Cole-Parmer Instrument Company Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 50. STEMCELL Technologies Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 51. Illumina, Inc Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 52. AB Sciex Private Limited Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 53. Agilent Technologies Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 54. Danaher Corporation Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 55. Bio-Rad Laboratories Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 56. Qiagen NV Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 57. Merck KgaA Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 58. Shimadzu Corporation Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 59. PerkinElmer Inc Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 60. Eurofins Scientific Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 61. Aurora Biomed Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 62. Sartorius AG Revenue Growth Rate in COVID-19 Vaccine Development Tools Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
